Abstract
Background
Predicting the long-term outcome after traumatic brain injury (TBI) is an important component of treatment strategy. Despite dramatically improved emergency management of TBI and apparent clinical recovery, most patients with TBI still may have long-term central nervous system (CNS) impairment.
Methods
Sixty-three patients with TBI were enrolled into the prospective study. Venous blood samples were taken at admission and every 24 h for a maximum of 6 consecutive days. Serum concentrations of the biomarkers S100B, neuron-specific enolase (NSE), GFAP, NF-H, secretagogin and Hsp70 were quantified immuno-luminometrically or by enzyme-linked immunosorbent assay. The outcome was evaluated 6 months after TBI using the Glasgow Outcome Scale (GOS) in all patients.
Results
The S100B levels in patients with worse outcome (GOS 4 or death) were already significantly higher at D0 (p < 0.001; p = 0.002). NSE levels were significantly higher in patients who died or had worse outcomes (p < 0.001; p = 0.003). Patients who had worse outcomes (GOS) or died had higher GFAP values (p < 0.001; p < 0.001), but their dynamics were similar over the same period. NF-H grew significantly faster in patients who had a worse GOS or died (p < 0.001; p = 0.001).
Conclusions
Although further prospective study is warranted, these findings suggest that levels of biomarkers correlate with mortality and may be useful as predictors of outcome in children with TBI.
Similar content being viewed by others
References
Anderson KJ, Scheff SW, Miller KM, Roberts KN, Gilmer LK, Yang C, Shaw G (2008) The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma 25:1079–1085
Bandyopadhyay S, Hennes H, Gorelick MH, Wells RG, Walsh- Kelly CM (2005) Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Acad Emerg Med 12:732–738
Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24:1793–1801
Bittigau P, Sifringer M, Pohl D, Stadthaus D, Ishimaru M, Shimizu H, Ikeda M, Lang D, Speer A, Olney JW, Ikonomidou C (1999) Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 45:724–735
Buki A, Povlishock JT (2006) All roads lead to disconnection?–Traumatic axonal injury revisited. Acta Neurochir (Wien) 148:181–193
Ciccarelli R, Di Iorio P, Bruno BG, D'Alimonte I, D'Onofrio M, Nicoletti F, Caciagli F (1999) Activation of A1 adenoside or mGlu3 metabotropic glutamate recepotrs enhances the relase of nerve growth factor and S-100β protein from cultured astrocytes. Glia 27:275–281
Cooper EH (1994) Neuron-specific enolase. Int J Biol Markers 4:205–210
Donato R (1986) S-100 proteins. Cell Calcium 7:123–145
Galea E, Dupouey P, Feinstein DL (1995) Glial fibrillary acidic protein mRNA isotypes: expression in vitro and in vivo. J Neurosci Res 41:452–461
Gartner W, Lang W, Leutmetzer F, Domanovits H, Waldhausl W, Wagner L (2001) Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)- binding protein. Cereb Cortex 11:1161–1169
Giza CC, Mink RB, Madikians A (2007) Pediatric traumatic brain injury: not just little adults. Curr Opin Crit Care 13:143–152
Guzhova I, Kislyakova K, Moskaliova O, Fridlanskaya I, Tytell M, Cheetham M, Margulis B (2001) In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res 914:66–73
Haqqani AS, Hutchison JS, Ward R, Stanimirovic DB (2007) Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J Neurotrauma 1:54–74
Heizmann CW, Fritz G, Schafer BW (2002) S100 proteins: structure, functions and pathology. Front Biosci 7:1356–1368
Herrmann M, Ehrenreich H (2003) Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 21:177–190
Herrmann M, Johnsson P, Romner B (2003) Molecular markers of brain damage: current state and future perspectives. Restor Neurol Neurosci 21:75–77
Institute of health information and statistics of the Czech republic (IHIS CR)—ÚZIS ČR, Aktuální informace č. 24/2011
Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1(7905):480–484
Lewis SB, Wolker RA, Miralia L, Yang C, Shaw G (2008) Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysma subarachnoid hemorrhage patiens. Journal of Cerebral Blood Flow & Metabolism 28:1261–1271
Li GC (1983) Induction of thermotolerance and enhanced heat shock protein synthesis in Chinese hamster fibroblasts by sodium arsenite and ethanol. J Cell Physiol 115:116–122
Marshall LF, Marshall SB, Klauber MR, Van Berkum CM, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA (1992) The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 9(suppl 1):S287–S292
Náhlovský J (2006) Neurochirurgie. Galén, Karolinum, Praha
Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S (2004) Release of S100B differs during ischemia and reperfusion of the liver, the gut and the kidney in rats. Shock 21:72–76
Pelinka LE, Hertz H, Mauritz W et al (2005) Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock 24:119–123
Pelinka LE, Jafardamar M, Redl H, Bahrami S (2004) Neuronspecific enolase is increased in plasma after hemorrhagic shock and after bilateral femur fracture without traumatic brain injury in the rat. Shock 22:88–91
Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H (2004) GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21:1553–1561
Pelinka LE, Szalay L, Jafarmadar M, Schmidhammer R, Redl H, Bahrami S (2003) Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br J Anaesth 91:595–597
Pockley AG (2003) Heat shock proteins as regulators of the immune response. Lancet 362:469–476
da Rocha AB, Zanoni C, de Freitas GR, André C, Himelfarb S, Schneider RF, Grivicich I, Borges L, Schwartsmann G, Kaufmann M, Regner A (2005) Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J Neurotrauma 22:966–977
Rogstam A, Linse S, Lindqvist A, James P, Wagner L, Berggard T (2007) Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J 401:353–363
Rustandi RR, Drohat AC, Baldisseri DM, Wilder PT, Weber DJ (1998) The Ca2+ dependent interaction of S100B with a peptide derived from p53. Biochemistry 37:1951–1960
Sarto C, Binz P, Mocarelli P (2000) Heat shock proteins in human cancer. Electrophoresis 21:1218–1226
Strong MJ, Strong WL, Jaffe H, Traggert B, Sopper MM, Pant HC (2001) Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis. J Neurochem 76:1315–1325
Shaw G, Yang C, Zhang L, Cook P, Pike BR, Hill WD (2007) Characterization of the bovine neurofilament NF-M protein and cDNA sequence and identification of in vitro and in vivo calpain cleavage sites. Biochem Biophys Res Commun 325:619–625
Unden J, Christensson B, Bellner J, Alling C, Romner B (2004) Serum S100B levels in patients with cerebral and extracerebral infectious disease. Scand J Infect Dis 36:10–13
Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E (1989) S-100B protein in blood and urine during open-heart surgery. Clin Chem 35:1942–1944
Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84
Tepas JJ, Mollitt DL, Albert JL, Bryant M (1987) The Pediatric Trauma Score as a predictor of injury severity in the injured child. J Pediat Surg 22:8–14
Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F (2006) Rapid elimination of protein S-100B from serum after minor head trauma. J Neurotrauma 23:149–155
Whitaker-Azmitia PM, Murphy R, Azmitia EC (1990) Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 528:155–158
Wiesmann M, Missler U, Hagenstrom H, Gottmann D (1997) S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir 139:1155–1160
Zylicz M, King F, Wawrzynow A (2001) Hsp70 interactions with the p53 tumour supression protein. EMBO J 20:4634–4638
Conficts of interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment
This article deals with an important point—prediction of outcome after head trauma in the pediatric population. Biomarkers are very interesting in this respect, especially if they can provide us with predictions not possible to judge from other key points such as the Pediatric Trauma Scale score. Although more work is needed to determine the exact use of these markers, this study provides us with interesting results for further research and hopefully with benefits for the pediatric patient.
Jane Skjoth-Rasmussen
Copenhagen, Denmark
Rights and permissions
About this article
Cite this article
Žurek, J., Fedora, M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir 154, 93–103 (2012). https://doi.org/10.1007/s00701-011-1175-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-011-1175-2